BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36792014)

  • 1. Cisplatin and Albumin-Based Gold-Cisplatin Nanoparticles Enhance Ablative Radiation Therapy-Induced Antitumor Immunity in Local and Distant Tumor Microenvironment.
    Chen JL; Yang SJ; Pan CK; Lin LC; Tsai CY; Wang CH; Huang YS; Lin YL; Kuo SH; Shieh MJ
    Int J Radiat Oncol Biol Phys; 2023 Aug; 116(5):1135-1149. PubMed ID: 36792014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postablation Modulation after Single High-Dose Radiation Therapy Improves Tumor Control via Enhanced Immunomodulation.
    Savage T; Pandey S; Guha C
    Clin Cancer Res; 2020 Feb; 26(4):910-921. PubMed ID: 31757878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin nanoparticles boost abscopal effect of radiation plus anti-PD1 therapy.
    Wang Y; Shen N; Wang Y; Li M; Zhang W; Fan L; Liu L; Tang Z; Chen X
    Biomater Sci; 2021 Apr; 9(8):3019-3027. PubMed ID: 33656040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMAC Mimetic Debio 1143 and Ablative Radiation Therapy Synergize to Enhance Antitumor Immunity against Lung Cancer.
    Tao Z; McCall NS; Wiedemann N; Vuagniaux G; Yuan Z; Lu B
    Clin Cancer Res; 2019 Feb; 25(3):1113-1124. PubMed ID: 30352911
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Cai Z; Liu R; Chan C; Lu Y; Winnik MA; Cescon DW; Reilly RM
    Mol Pharm; 2022 Nov; 19(11):4199-4211. PubMed ID: 36287201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NKTR-214 immunotherapy synergizes with radiotherapy to stimulate systemic CD8
    Walker JM; Rolig AS; Charych DH; Hoch U; Kasiewicz MJ; Rose DC; McNamara MJ; Hilgart-Martiszus IF; Redmond WL
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32457127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-Day Spacing of Two Fractionated Ablative Radiotherapies Enhances Antitumor Immunity.
    Kim H; Lee E; Cho H; Kim E; Jang WI; Yang K; Lee YJ; Kim TJ; Kim MS
    Int J Radiat Oncol Biol Phys; 2024 Feb; 118(2):498-511. PubMed ID: 37717785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin Facilitates Radiation-Induced Abscopal Effects in Conjunction with PD-1 Checkpoint Blockade Through CXCR3/CXCL10-Mediated T-cell Recruitment.
    Luo R; Firat E; Gaedicke S; Guffart E; Watanabe T; Niedermann G
    Clin Cancer Res; 2019 Dec; 25(23):7243-7255. PubMed ID: 31506388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphonuclear-MDSCs Facilitate Tumor Regrowth After Radiation by Suppressing CD8
    Zhang Md J; Zhang Md L; Yang Md Y; Liu Md Q; Ma Md H; Huang Md A; Zhao Md Y; Xia Md Z; Liu Md T; Wu Md G
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1533-1546. PubMed ID: 33238192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effects of anti-PDL-1 with ablative radiation comparing to other regimens with same biological effect dose based on different immunogenic response.
    Alinezhad M; Bakhshandeh M; Rostami E; Alimohamadi R; Mosaffa N; Jalali SA
    PLoS One; 2020; 15(4):e0231507. PubMed ID: 32287292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin augments cytotoxic T-lymphocyte-mediated antitumor immunity in poorly immunogenic murine lung cancer.
    Merritt RE; Mahtabifard A; Yamada RE; Crystal RG; Korst RJ
    J Thorac Cardiovasc Surg; 2003 Nov; 126(5):1609-17. PubMed ID: 14666041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anlotinib Enhances the Antitumor Activity of High-Dose Irradiation Combined with Anti-PD-L1 by Potentiating the Tumor Immune Microenvironment in Murine Lung Cancer.
    Yuan M; Zhai Y; Men Y; Zhao M; Sun X; Ma Z; Bao Y; Yang X; Sun S; Liu Y; Zhang W; Hui Z
    Oxid Med Cell Longev; 2022; 2022():5479491. PubMed ID: 35154567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Myeloid-derived Suppressor Cells and Programmed Death Ligand 1 Confers Therapeutic Advantage of Ablative Hypofractionated Radiation Therapy Compared With Conventional Fractionated Radiation Therapy.
    Lan J; Li R; Yin LM; Deng L; Gui J; Chen BQ; Zhou L; Meng MB; Huang QR; Mo XM; Wei YQ; Lu B; Dicker A; Xue JX; Lu Y
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):74-87. PubMed ID: 29619980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced systemic antilymphoma immune response by photothermal therapy with CpG deoxynucleotide-coated nanoparticles.
    Lin AY; Choi B; Sim T; Yang E; Choi H; Behdad A; Kim DH; Gordon LI
    Blood Adv; 2022 Aug; 6(15):4581-4592. PubMed ID: 35687489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin in combination with cisplatin makes favorable tumor-immune microenvironment for immunotherapy of head and neck squamous cell carcinoma.
    Kwon M; Nam GH; Jung H; Kim SA; Kim S; Choi Y; Lee YS; Cho HJ; Kim IS
    Cancer Lett; 2021 Dec; 522():198-210. PubMed ID: 34571082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation dose and schedule influence the abscopal effect in a bilateral murine CT26 tumor model.
    Ghaffari-Nazari H; Alimohammadi M; Alimohammadi R; Rostami E; Bakhshandeh M; Webster TJ; Mahmoodi Chalbatani G; Tavakkol-Afshari J; Amir Jalali S
    Int Immunopharmacol; 2022 Jul; 108():108737. PubMed ID: 35417831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining bempegaldesleukin (CD122-preferential IL-2 pathway agonist) and NKTR-262 (TLR7/8 agonist) improves systemic antitumor CD8
    Rolig AS; Rose DC; McGee GH; Rubas W; Kivimäe S; Redmond WL
    J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35444059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abscopal Effects With Hypofractionated Schedules Extending Into the Effector Phase of the Tumor-Specific T-Cell Response.
    Zhang X; Niedermann G
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):63-73. PubMed ID: 29534901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-1 blockade augments CD8
    Nakasuka T; Ohashi K; Nishii K; Hirabae A; Okawa S; Tomonobu N; Takada K; Ando C; Watanabe H; Makimoto G; Ninomiya K; Fujii M; Kubo T; Ichihara E; Hotta K; Tabata M; Kumon H; Maeda Y; Kiura K
    Lung Cancer; 2023 Apr; 178():1-10. PubMed ID: 36753780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caloric Restriction Impairs Regulatory T cells Within the Tumor Microenvironment After Radiation and Primes Effector T cells.
    Manukian G; Kivolowitz C; DeAngelis T; Shastri AA; Savage JE; Camphausen K; Rodeck U; Zarif JC; Simone NL
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1341-1349. PubMed ID: 33647370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.